Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Publication year range
1.
Int Immunopharmacol ; 124(Pt B): 110947, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37742369

ABSTRACT

BACKGROUND: Non-small cell lung cancer (NSCLC) often exhibits elevated Secreted Protein Acidic and Cysteine-Rich (SPARC) expression. In this study, we investigated the impact of SPARC expression on clinicopathologic features, pembrolizumab response, and prognosis in metastatic NSCLC patients. METHODS: Thirty-six patients diagnosed with metastatic NSCLC without actionable driver mutation and who received pembrolizumab with or without chemotherapy were included in this study. PD-L1 and SPARC expression were evaluated, with PD-L1 expression categorized based on tumor proportion score and SPARC staining intensity graded as 1+, 2+, and 3 +. Patients' characteristics were compared across groups, and possible predictive markers were determined by binary logistic regression analysis. RESULTS: No significant associations were found between SPARC expression and smoking status, histopathological tumor type, T and N status, and liver and bone metastasis. Higher SPARC expression was significantly linked to lower brain metastasis rates but higher CNS progression rates (p = 0.022 and p = 0.011, respectively. The objective response rate (ORR) showed a trend of being higher in the SPARC 1 + group (85.7% vs. 43.8% and 50.0% in 2 + and 3 + groups, respectively, p = 0.052. Univariate analysis did not find SPARC expression to be a significant prognostic factor for progression-free survival (PFS) (p = 0.7) and overall survival (OS) (p = 0.07).SPARC 1 + expression negatively affected the pembrolizumab response(p = 0.04,OR:0.11, 95%CI 0.01-0.92). CONCLUSIONS: Our study sheds light on a novel aspect of SPARC expression as a potential predictor of pembrolizumab response and a marker for CNS progression in metastatic NSCLC patients treated in the first-line setting.


Subject(s)
Brain Neoplasms , Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , Humans , Carcinoma, Non-Small-Cell Lung/pathology , Lung Neoplasms/genetics , B7-H1 Antigen/genetics , B7-H1 Antigen/metabolism , Brain Neoplasms/drug therapy , Osteonectin/genetics , Osteonectin/therapeutic use
2.
Braz J Cardiovasc Surg ; 38(4): e20220268, 2023 07 04.
Article in English | MEDLINE | ID: mdl-37402277

ABSTRACT

Coarctation of the aorta is a well-known congenital cardiovascular disorder that typically occurs within proximity to the ductus arteriosus. The ascending aorta, distal descending aorta, and abdominal aorta are segments which are prone to development of an atypical coarctation. The etiologies of atypical cases are usually associated with various types of vasculitis syndromes or underlying genetic disorders. In this report, we present a 24-year-old female patient with an ascending aortic coarctation which developed secondary to an atherosclerotic process.


Subject(s)
Aortic Coarctation , Cardiovascular Diseases , Ductus Arteriosus, Patent , Takayasu Arteritis , Humans , Female , Young Adult , Adult , Aortic Coarctation/complications , Aortic Coarctation/diagnostic imaging , Aortic Coarctation/surgery , Takayasu Arteritis/complications , Takayasu Arteritis/diagnostic imaging , Aorta, Abdominal , Aorta, Thoracic
3.
Rev. bras. cir. cardiovasc ; 38(4): e20220268, 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1449562

ABSTRACT

ABSTRACT Coarctation of the aorta is a well-known congenital cardiovascular disorder that typically occurs within proximity to the ductus arteriosus. The ascending aorta, distal descending aorta, and abdominal aorta are segments which are prone to development of an atypical coarctation. The etiologies of atypical cases are usually associated with various types of vasculitis syndromes or underlying genetic disorders. In this report, we present a 24-year-old female patient with an ascending aortic coarctation which developed secondary to an atherosclerotic process.

4.
Neurocirugía (Soc. Luso-Esp. Neurocir.) ; 33(6): 334-339, nov.-dic. 2022. ilus
Article in English | IBECS | ID: ibc-212991

ABSTRACT

Background Pancreatic cancer is a common gastrointestinal malignancy, and is often associated with a poor prognosis. Although liver is generally seen as a distant metastasis point, it has been shown that it can metastasize to any organ, especially the gastrointestinal tract, and approximately 0.3% of metastases are observed in spinal cord. Case description We report a 36-year-old woman with a prior history of pancreatic adenocarcinoma who presented to us with a thoracic intramedullary lesion and recent onset of neurological deficits. She underwent surgery with histological confirmation of a diagnosis of metastatic adenocarcinoma. Conclusion To our knowledge there is no prior report of pure intramedullary spinal cord metastasis from a pancreatic adenocarcinoma in the literature. We report the present patient in view of the rarity of intramedullary spinal cord metastasis and its clinical significance. Although intramedullary metastases are rare, they should be investigated in every patient with malignancy and progressive neurological deficit. While its general prognosis is poor regardless of the type of treatment, early diagnosis and treatment is important in terms of quality of life and survival (AU)


Antecedentes El cáncer de páncreas es una neoplasia maligna gastrointestinal común y, a menudo, se asocia con un mal pronóstico. Aunque el hígado generalmente se ve como un punto de metástasis distante, se ha demostrado que puede hacer metástasis a cualquier órgano, especialmente al tracto gastrointestinal, y aproximadamente el 0,3% de las metástasis se observan en la médula espinal. Descripción del caso Presentamos una mujer de 36 años con antecedentes de adenocarcinoma de páncreas que se presentó con una lesión intramedular torácica y de reciente aparición de déficits neurológicos. Fue intervenida quirúrgicamente con confirmación histológica de diagnóstico de adenocarcinoma metastásico. Conclusión Hasta donde sabemos, no existe en la literatura ningún informe previo de metástasis intramedular pura de la médula espinal de un adenocarcinoma pancreático. Presentamos el presente paciente en vista de la rareza de la metástasis intramedular de la médula espinal y su importancia clínica. Aunque las metástasis intramedulares son raras, deben investigarse en todo paciente con neoplasia maligna y déficit neurológico progresivo. Si bien su pronóstico general es malo independientemente del tipo de tratamiento, el diagnóstico y el tratamiento precoces son importantes en términos de calidad de vida y supervivencia (AU)


Subject(s)
Humans , Female , Adult , Spinal Cord Neoplasms/secondary , Adenocarcinoma/secondary , Pancreatic Neoplasms/pathology , Spinal Cord Neoplasms/surgery , Adenocarcinoma/surgery , Magnetic Resonance Imaging , Laminectomy
5.
Neurocirugia (Astur : Engl Ed) ; 33(6): 334-339, 2022.
Article in English | MEDLINE | ID: mdl-36333089

ABSTRACT

BACKGROUND: Pancreatic cancer is a common gastrointestinal malignancy, and is often associated with a poor prognosis. Although liver is generally seen as a distant metastasis point, it has been shown that it can metastasize to any organ, especially the gastrointestinal tract, and approximately 0.3% of metastases are observed in spinal cord. CASE DESCRIPTION: We report a 36-year-old woman with a prior history of pancreatic adenocarcinoma who presented to us with a thoracic intramedullary lesion and recent onset of neurological deficits. She underwent surgery with histological confirmation of a diagnosis of metastatic adenocarcinoma. CONCLUSION: To our knowledge there is no prior report of pure intramedullary spinal cord metastasis from a pancreatic adenocarcinoma in the literature. We report the present patient in view of the rarity of intramedullary spinal cord metastasis and its clinical significance. Although intramedullary metastases are rare, they should be investigated in every patient with malignancy and progressive neurological deficit. While its general prognosis is poor regardless of the type of treatment, early diagnosis and treatment is important in terms of quality of life and survival.


Subject(s)
Adenocarcinoma , Pancreatic Neoplasms , Spinal Cord Neoplasms , Female , Humans , Adult , Adenocarcinoma/surgery , Adenocarcinoma/secondary , Quality of Life , Pancreatic Neoplasms/surgery , Spinal Cord Neoplasms/diagnostic imaging , Spinal Cord Neoplasms/surgery , Pancreatic Neoplasms
6.
Article in English, Spanish | MEDLINE | ID: mdl-33994284

ABSTRACT

BACKGROUND: Pancreatic cancer is a common gastrointestinal malignancy, and is often associated with a poor prognosis. Although liver is generally seen as a distant metastasis point, it has been shown that it can metastasize to any organ, especially the gastrointestinal tract, and approximately 0.3% of metastases are observed in spinal cord. CASE DESCRIPTION: We report a 36-year-old woman with a prior history of pancreatic adenocarcinoma who presented to us with a thoracic intramedullary lesion and recent onset of neurological deficits. She underwent surgery with histological confirmation of a diagnosis of metastatic adenocarcinoma. CONCLUSION: To our knowledge there is no prior report of pure intramedullary spinal cord metastasis from a pancreatic adenocarcinoma in the literature. We report the present patient in view of the rarity of intramedullary spinal cord metastasis and its clinical significance. Although intramedullary metastases are rare, they should be investigated in every patient with malignancy and progressive neurological deficit. While its general prognosis is poor regardless of the type of treatment, early diagnosis and treatment is important in terms of quality of life and survival.

7.
Vasc Endovascular Surg ; 50(6): 415-20, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27334478

ABSTRACT

A 36-year-old young woman with a medical history of recurrent pulmonary embolism and chronic pelvic pain was admitted to our hospital. Contrast-enhanced imaging techniques revealed a large left renal vein aneurysm with a coexisting vascular mass. The patient was operated on electively, and the left kidney was autotransplanted to the right ileac fossa following the ex vivo resection of the vascular mass and the left renal vein aneurysm. Herein, we report an unusual coexistence of a vascular mass and recurrent pulmonary embolism treated successfully with our surgical treatment strategy.


Subject(s)
Aneurysm/surgery , Kidney Transplantation/methods , Lymphatic Vessels/surgery , Pulmonary Embolism/surgery , Renal Veins/surgery , Transplantation, Autologous , Vascular Malformations/surgery , Adult , Aneurysm/complications , Aneurysm/diagnostic imaging , Biopsy , Chronic Pain/etiology , Computed Tomography Angiography , Female , Humans , Lymphatic Vessels/abnormalities , Lymphatic Vessels/diagnostic imaging , Magnetic Resonance Imaging , Pelvic Pain/etiology , Phlebography/methods , Pulmonary Embolism/diagnostic imaging , Pulmonary Embolism/etiology , Recurrence , Renal Veins/abnormalities , Renal Veins/diagnostic imaging , Treatment Outcome , Vascular Malformations/complications , Vascular Malformations/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL
...